143 results about "Cannabis substance" patented technology

The system and techniques disclosed herein perform advanced and automatic age verification. The age verification system (AVS) is designed for automated and accurate age-restricted access control and age verification for the sale of age-controlled products. For example, the AVS can be employed to perform age-verification to permit the legal sale / purchase of age-controlled products such as alcohol, tobacco, cannabis, and the like, and Also, the AVS can be used to control legal access to age-restricted areas such as casinos, movie theaters, bars, and the like. The AVS can include a scanner for scanning a barcode printed on an identification (ID) card, an application, and a computer unit having output devices for generating visual, audible, and electronic signals to view, alert, and control age-restricted entry and control the sale of age-controlled products. The AVS can include automatic door lock functionality that supports age-restricted access control.

The present invention relates to a cannabidiol (CBD) type cannabinoid compound for use as a medicament. The CBD-type cannabinoid, cannabidiol-C6 (CBD-C6), is a naturally occurring cannabinoid that can be found in minor quantities in the cannabis plant. Furthermore, the cannabinoid can be produced by synthetic means and a method for the production of CBD-C6 is described herein. In addition, disclosed herein are data which demonstrate the efficacy of CBD-C6 in models of disease.

The present invention relates to the use of cannabidiol (CBD) in the treatment of Sturge Weber syndrome. CBD ap-pears particularly effective in reducing all types of seizures and non-seizure symptoms in patients suffering with Sturge Weber syndrome. Preferably the CBD used is in the form of a highly purified extract of cannabis such that the CBD is present at greater than 98% of the total extract (w / w) and the other components of the extract are characterised. In particular the cannabinoid tetrahydrocan-nabinol (THC) has been substantially removed, to a level of not more than 0.15% (w / w) and the propyl analogue of CBD, cannabidivarin, (CBDV) is present in amounts of up to 1%. Alternatively, the CBD may be a synthetically produced CBD.

Preparation of cannabinoid formulations containing: Δ9-tetrahydrocannabinol (Δ9-THC), Δ8-tetrahydrocannabinol (Δ8-THC), Δ9-tetrahydrocannabinolic acid (THCa), cannabidiol (CBD), cannabidiolic acid (CBDa), cannabigero (CBG), cannabichromene (CBC) and cannabinol (CBN), either alone or in combinations henceforth known as cannabis, have been created using an emulsification process to encapsulate cannabinoids. The aqueous-based method involves micellular encapsulation of cannabinoids, a method that has been used to increase the bioavailability of poorly permeable, lipophilic drugs. The present invention demonstrates the viability of transdermal delivery with gels and patches for consistent and sustained cannabinoid dosing.

The present disclosure relates to a filter for a smoking device, such as, but not limited to, a water pipe, or a cigarette, such as, but not limited to, a cannabis cigarette. The filter includes a body that is positionable over a mouthpiece of the smoking device, to filter impurities from smoke drawn therethrough, and a base that secures the body over the mouthpiece such that smoke is drawn therethrough, prior to inhalation by a user. The body can include one of more filtration layers, such as a first layer formed from a material selected to filter carcinogens and other impurities from the smoke prior to inhalation, and a second layer formed from a material selected to minimize or prevent the transmission of bacteria, viruses, or other contagions from a user's mouth to the smoking device. Each of the filtration layers can also be formed from one or more materials.

The present invention provides for a method for obtaining an oil extract of cannabis. The method includes: (a) contacting cannabis biomass and an edible oil; (b) pressing between a pair of plates to provide spent cannabis and an oil extract of cannabis; and (c) separating the spent cannabis biomass and the oil extract of cannabis.

The present disclosure concerns methods for reducing nicotine dependency, i.e. by reducing tobacco smoking and promoting tobacco smoking secession; and by reducing marijuana dependency, i.e. by reducing marijuana smoking and promoting marijuana smoking cessation. More particularly the present disclosure concerns formulations of cannabinoids for use in reducing nicotine and marijuana dependency and promoting tobacco and marijuana smoking secession.

A vaporizing device includes a main body with a chamber extending between first and second openings. A condensation cup at the bottom of the chamber collects moisture and unvaporized substances. A stem extends through the second opening, and a mouthpiece extends through the first opening. The mouthpiece is a tubular member with an open end and a plurality of outlet openings. Stoppers secure the mouthpiece and stem within the chamber. A magnetic tool may be provided for applying vaporizable substances. In use, a section of the stem is locally heated to vaporization temperature, a substance is applied to the heated section, and vapor is drawn through the mouthpiece. The condensation cup prevents residue from reaching the user, maintaining cleanliness and hygiene. The device supports tool-free disassembly and is suitable for tobacco, cannabis, herbal blends, and concentrates.

Aseptic product processing systems and methods may include a hopper for introducing the product into the system and one or more components through which the product flows as it is processed, an enclosure surrounding one or more of the components, a gassing assembly comprising a plurality of gassing elements to maintain a substantially constant flow of inert gas over the product as it travels through the system components, and a filtered gas recirculation system that recirculates air or filtered gas through the enclosure. Such systems may be particularly advantageous for use in the cannabis industry.

The disclosed technology includes cannabinoid oral products, and methods for making same. In some embodiments, the oral products are pouches including cannabinoid infused wafers. In some embodiments, the method of making the cannabinoid oral products includes preparing an emulsion, preparing a spray dry solution, spray drying solution into cannabinoid and carbohydrate particles, preparing a paste, preparing a wafer in a heated vacuum oven, fragmenting the wafer into cannabinoid infused wafer fragments, mixing the cannabinoid infused wafer fragments with starch, and dispensing the cannabinoid infused wafer fragments into pouches. The methods may also include labeling the oral products, for example, with a THC warning symbol.

Compositions including Δ-9-tetrahydrocannabinol (THC) and a carbonic andydrase inhibitor and methods of using these compositions for the treatment of obstructive sleep apnoea (OSA). The treatment method also includes administering dronabinol and acetazolaminde and combinations thereof to a subject in need thereof.

An infusion kit and a method for using said kit for infusing a base substance with an additive substance. The additive substance is deposited into a permeable container, which is itself inserted into a non-permeable container. The base substance is then added to the non-permeable container and the non-permeable container is heated to thereby infuse the base substance with the additive substance. In one embodiment, the additive substance is roasted in the permeable container before infusion begins. In some embodiments, a non-permeable casing encloses the permeable container during roasting. In a preferred embodiment, the non-permeable container is heated by immersion in a temperature-controlled liquid bath system, such as would be found in a sous-vide or similar system. However, many other heating systems may be used. The additive substance may be derived from a plant, including but not limited to cannabis.

A fluid dispenser for discharging a nicotine and / or cannabis-containing fluid as a replacement for tobacco products consumed by burning same, including a fluid store for storing the fluid before output, a mouthpiece for discharging the fluid, a connecting fluid channel and an outlet valve assembly, with which the fluid channel is opened and closed. The outlet valve assembly has an elastically deformable tube section forming part of the fluid channel, and an actuation surface is located on an outer side of the dispenser for actuating the outlet valve assembly. This actuation surface is coupled to a tube-shaping segment, with which the tube section is deformed from a state in which the fluid channel is closed into a state in which the fluid channel is open by applying force to the actuation surface, to thereby allow for the discharge of fluid.

Filters of conventional design consist of a small paper tube which is filled with activated carbon and is closed at both ends by cellulose fibres and / or ceramic caps. Filters consisting only of cellulose also exist. The filters are used to rotate them with cigarette paper to form a cigarette or a joint. In normal use, one of the filter ends can be singed or burned when the cigarette or the joint is smoked to the end. In addition, specifically in the case of cannabis, oils emerging as a result of heat can clog the cellulose, but in particular also the small air passages of ceramic caps. The invention is intended, by means of the thermal insulation, to prevent scorching and clogging of the filter elements. The filter elements consist of cellulose and carbon or consist of ceramic cap / carbon or only cellulose and are to be placed centrally in a small tube consisting of paper. The cavities between the filter elements and the end of the tube are to be filled with specially shaped inserts made of paper or ceramic. The extension of the filter on both sides by the small paper tube is intended to ensure thermal insulation and to prevent the embers from being in direct contact with the cellulose filter or with the ceramic cap. As a result of the enlarged area, the specially shaped inserts made of paper or ceramic are intended to prevent clogging by emerging oils. In addition, the inserts prevent tobacco or cannabis particles from being able to fall unhindered into the paper tube.

Compositions comprising 0.1-50 % delta-9-tetrahydrocannabinol and / or cannabidiol in forms suitable for continuous delivery and use thereof in the treatment of a variety of diseases and pathological disorders are disclosed. In preferred embodiments, the compositions are in a form suitable for delivery via a portable infusion pump or transdermal patch. The disorders to be treated include pain, cancer, seizure disorders, and Parkinson's disease. Depending on the disorder to be treated, the compositions may optionally further comprise additional active agents such as dopaminergic agents.

The present invention provides a novel room-temperature extraction system and method for cannabis and hemp, utilizing custom membrane filtration to efficiently isolate cannabinoids, terpenes, and other bioactive compounds while reducing energy consumption. This multi-stage system begins with a custom milling machine that preprocesses biomass by separating non-target components, such as cellulose-rich stalks, to improve extraction efficiency. The core extraction process employs a series of custom membranes designed to selectively filter cannabinoids and terpenes, minimizing impurities without the need for traditional sub-zero cooling. Each membrane stage incorporates solvent recovery to recycle ethanol, reducing waste and operational costs. In the final stage, a custom concentrator removes residual ethanol, decarboxylates THCa to THC, and crystallizes sugars to prevent downstream clogging. This room-temperature extraction system significantly enhances yield, purity, and sustainability, making it a scalable and cost-effective solution for cannabis and hemp processing industries, as well as applicable for pharmaceutical and nutraceutical uses.

The invention provides certain compositions and methods for dental care, which alone or in combination with other dental technologies can help to achieve better outcomes in terms of the enhancement of oral hygiene as regards to preservation of the healthy oral and / or dental flora, minimization or a reduction of the proportion of harmful bacteria, and further facilitate the enhancement of a more healthy appearance of teeth and gums. The oral formulation for improving oral and / or dental hygiene, and / or for enhancing the healthy appearance of teeth and gums, comprises Dead Sea salt and at least one synthetic, semi-synthetic or natural cannabinoid, a precursor, a derivative, or any combination thereof, or an extract of a cannabis plant.

A method and system in accordance with the subject invention establishes industry norms for every step in the production, cultivation, harvest, and packaging process for a regulated industry to follow with respect to a regulated product. An embodiment relates to the regulated product cannabis where product is accurately recorded into the system is legal while any product that is not recorded into the system is illegal.

Provided herein are methods of treating cannabinoid intoxication. Further provided herein are metrics for evaluation Cannabis intoxication and the amelioration thereof.

Microemulsion beverages are described where hydrophobic liquid droplets are distributed in a continuous hydrophilic liquid phase. The described microemulsion beverages may be thought of as modified oil-in-water (MOIHW) microemulsions, where both the “oil” and “water” phases of the microemulsion are modified. The oil phase droplets of the MOIHW microemulsion are modified with alcohol and can solubilize oil-soluble species, including cannabis extracts. The polar continuous “water” phase of the MOIHW microemulsion is modified with a sugar or sugar alcohol.

The present invention relates to the use of cannabidiol (CBD) in the treatment of patients with childhood-onset epilepsy who are concurrently taking caffeine. Where the CBD is used in combination with caffeine, caution should be taken. For example, the dose of either the CBD and / or caffeine may be required to be reduced. Moreover, the patient may need to be monitored for side effects of said drug-drug interaction. Preferably the CBD used is in the form of a highly purified extract of cannabis such that the CBD is present at greater than 95% of the total extract (w / w) and the other components of the extract are characterised. In particular the cannabinoid tetrahydrocannabinol (THC) has been substantially removed, to a level of not more than 0.15% (w / w) and the propyl analogue of CBD, cannabidivarin, (CBDV) is present in amounts of up to 1%. Alternatively, the CBD may be a synthetically produced CBD.

A container for flexible product with built-in tubing includes a flexible container having a container cavity therein, a dispensing apparatus provided on a container wall of the container, and a tubing transcending into the container cavity through the dispensing apparatus. The container is adapted for human utilization for packaging or consumption, for example, but not limited to, oil, pills, creams, lotions, fruit, ice products, pre-packaged meals, cannabis, ointments, powers, lotions, films, tablets, capsules, and medications, wherein the opening tubing / orifice is sealed and enclosed by a sealing flap / cover and is unsealed when the sealing flap / cover is open for ensuring hygiene and an extended shelf life of the product within the durable or flexible package that is fixed or portable with one or more fasteners.

A mechanism for monitoring cannabis and predicting or determining a harvesting time. A sensing arrangement generates a temporal sequence of VOC values, each representing a measured amount of a first set of one or more volatile organic compounds (VOCs) in the air surrounding some cannabis. This temporal sequence is then processed to determine a harvesting time, at which the cannabis is ready for harvesting (e.g., meets some predetermined criteria for achieving a harvesting goal).

This invention provides methods for the synthesis of cannabidiol and its analogues, as well as related compounds, formulations, and methods of use. [Solution] Methods are provided for the synthesis of oliveitol, oliveitol analogs, cannabidiol (CBD), CBD analogs, and other cannabinoids. One method uses phloroglucinol or phloroglucinol analogs as starting materials. The synthesis is stereospecific, efficient, selective, cost-effective, and THC((-)-trans-Δ 9 There is little to no possibility of generating (tetrahydro-cannabinol) or any other psychoactive by-products. Shortened synthesis is also provided, as well as new cannabinoids, pharmaceutical formulations, and methods of use.

An assembly and a method of attaching a flavor to Cannabis or other smokable materials by having a fixed roller 6 and a rolling flavor tube 1 and back roller 3 combination which slides on the fixed roller 6, thereby dispensing the flavor.

A method and system in accordance with the subject invention establishes industry norms for every step in the production, cultivation, harvest, and packaging process for a regulated industry to follow with respect to a regulated product. An embodiment relates to the regulated product cannabis where product is accurately recorded into the system is legal while any product that is not recorded into the system is illegal.

The present invention relates to a process for purifying cannabinoids, specifically cannabidiol, in a substantially pure form from herbal material. This process involves a sequence of purification steps including winterization, co-crystallization, dissociation, decarboxylation, and crystallization. Cannabidiol is purified from an extract of herbal material containing approximately 50-70% cannabidiolic acid (CBDA) and 10-20% cannabidiol (CBD), along with other cannabinoids. The substantially pure form of cannabidiol can be used in medicaments for treating various diseases or conditions. The invention also relates to co-crystals of L-proline and cannabidiolic acid and their use in obtaining substantially pure cannabidiol free from tetrahydrocannabinol (THC).

Tailored chromatographic media and methods for using the tailored chromatographic media to purify mixtures extracted from cannabis to obtain a cannabinoid having greater than about 90% purity. In an embodiment, the tailored chromatographic media may comprise a porous resin and / or porous carbon and have a surface area of greater than about 900 m2 / g, wherein the tailored chromatographic media may further comprise micropores, mesopores, macropores, wherein the tailored chromatographic media may further comprise at least two distributions of macroporous pore sizes, wherein the at least two distributions of macroporous pore sizes may comprise a first population having a macroporous pore size denoted x and a second population having a macroporous pore size denoted y, wherein a ratio of x / y may be about 1:1, and wherein the tailored chromatographic media may further comprise an anionic polysaccharide and a functional moiety.